Cn / En

CM05280


CM05280

Key word结直肠癌, PDX, 体内药效,体外药效,免疫系统人源化,5-FU, DS8201, DXD, SN38, TAS-102, 奥沙利铂, 奥希替尼, 多西他赛, 恩考拉非尼, 吉西他滨, 拉帕替尼, 雷替曲塞, 芦康莎妥珠单抗, 曲美替尼, 顺铂, 丝裂霉素C, 依维莫司, 长春新碱, 紫杉醇,

Model Information

Model IDCM05280
Cancer Type结直肠癌(肝转移)
Cell Subtype腺癌
Differentiation中分化
Collection Site肝
Metastatic Site肝转移
GradeIVA
TNM stagingTxNxM1a
IHC diagnosisCmet(3+), EGFR(3+), HER2(0), KI67(70%+), MLH1(+), MSH2(+), MSH6(+), PMS2(+)
Pathology diagnosis诊断:结肠癌肝转移术后 1(原发灶部位1-右半结肠,2-横结肠,3-左半结肠,4-乙状结肠,5-直肠)免疫组化结果显示:Cmet (3+), EGFR (3+), HER2 (0), Ki67 (70%+),MLH1 (+), MSH2 (+), MSH6 (+),PMS2(+)。[补充报告日期]2019/8/13 19: 30: 16[补充报告医生]王海月
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs